Table 1.
Baseline characteristics of participants in Analysis-1 and Analysis-2a.
| Analysis-1 (n = 49) | Analysis-2 (n = 368) | |
|---|---|---|
| Demographics | ||
| Age – years | 41 [31, 47] | 42 [32, 51] |
| Sex | ||
| Female – no. (%) | 42 (85.7) | 293 (79.6) |
| Male – no. (%) | 7 (14.3) | 75 (20.4) |
| Body mass indexb– kg/m2 | 21.2 [19.2, 23.4] | 21.2 [19.6, 23.5] |
| Smoking habit – no. (current/past/never) | 0/6/43 | 22/29/317 |
| Alcohol drinking habit – no. (daily/often/never) | 5/29/15 | 53/178/137 |
| Allergies – no. (%) | 9 (18.4) | 48 (13.1) |
| Comorbidities | ||
| Number of comorbidities – no. | 0 [0, 1] | 0 [0, 1] |
| Hypertension – no. (%) | 6 (12.2) | 41 (11.1) |
| Diabetes – no. (%) | 4 (8.2) | 10 (2.7) |
| Dyslipidemia – no. (%) | 6 (12.2) | 34 (9.2) |
| Hyperuricemia – no. (%) | 2 (4.1) | 10 (2.7) |
| Coronary heart disease – no. (%) | 0 (0.0) | 1 (0.3) |
| Arrhythmia – no. (%) | 3 (6.1) | 4 (1.0) |
| Stroke – no. (%) | 0 (0.0) | 0 (0.0) |
| Lung disease – no. (%) | 2 (4.1) | 24 (6.5) |
| Thyroid disease – no. (%) | 1 (2.0) | 13 (3.5) |
| Atopic dermatitis – no. (%) | 3 (6.1) | 37 (10.1) |
| Autoimmune disease – no. (%) | 0 (0.0) | 2 (0.1) |
| Cancer – no. (%) | 0 (0.0) | 13 (3.5) |
| Laboratory results | ||
| Total bilirubin – mg/dl | 0.60 [0.50, 0.85] | N/A |
| Aspartate aminotransferase – IU/l | 20.0 [15.5, 23.0] | N/A |
| Alanine aminotransferase – IU/l | 14.5 [11.5, 21.0] | N/A |
| γ-glutamyl transpeptidase – IU/l | 16.0 [14.0, 24.5] | N/A |
| Serum creatinine – mg/dl | 0.63 [0.57, 0.71] | N/A |
| Side effect of vaccination | ||
| Fever – no. (%) | 27 (55.1) | 178 (48.4) |
| Other side effects – no. (%) | 40 (81.6) | 243 (66.0) |
| Antipyretics – no. (%) | 35 (71.4) | 203 (55.2) |
N/A, not assessed.
a
Continuous variables are presented as median [1st quartile, 3rd quartile], and categorical variables are presented as number (%).
b
Body mass index was calculated using the following equation: body weight (kg)/height (m)/height (m).